• Visiting addressShow on map

    Sölveg 19, BMC D12

    221 84 Lund

    Sweden

Unit profile

Research

Our studies have identified a number of novel genes that are involved in the regulation of smooth muscle phenotype. In recent years, our research has been focused on the role of smooth muscle miRNAs in mechanosensing of smooth muscle. However, we are also investigating the importance of smooth muscle genes regulated by the actin cytoskeleton and hyperglycemia since we believe that these are two vital factors in the development of vascular disease. Cardiovascular disease is still the leading cause of death worldwide and novel treatment strategies are warranted. MicroRNAs represent a promising new class of drug targets against several disease states, including vascular disease.

Description

Both coding and non-coding (e.g. microRNAs) genes play a crucial role for the regulation of smooth muscle phenotype, which may have major implications for the progression of vascular disease. However, the genetic regulation of smooth muscle phenotype is just beginning to be understood and there is an immense potential for novel discoveries in the field. The general aim of our research is to identify new genes, both coding and non-coding, that are important for smooth muscle phenotype modulation in vascular disease.

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Collaborations the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or